帕博利珠单抗联合化疗一线治疗晚期非鳞状非小细胞肺癌:KEYNOTE-021研究G队列长期生存数据
Pembrolizumab With or Without Chemotherapy as First-Line Therapy for Advanced Nonsquamous NSCLC: Comments to Long-Term Overall Survival Data of Cohort G in KEYNOTE-021 Study
帕博利珠单抗联合化疗一线治疗晚期非鳞状非小细胞肺癌:KEYNOTE-021研究G队列长期生存数据 |
| 评价者:周建娅, 周建英 |
Pembrolizumab With or Without Chemotherapy as First-Line Therapy for Advanced Nonsquamous NSCLC: Comments to Long-Term Overall Survival Data of Cohort G in KEYNOTE-021 Study |
| |